TRPM7 and Myocardial fibrosis: Further research by Yang et al. revealed that AS-IV inhibits the TRPM7/TGF-β/Smads signaling pathway, reduces TRPM7 current, lowers calcium ion activity, and thereby attenuates the progression of myocardial fibrosis (Wei et al., 2020).